|
|
 |
| Epigenomics achieves key milestone in development of prostate cancer classification test |
Tuesday, 21.12.2004 |
|
| Press release, Berlin |
|
| Epigenomics AG and Roche Diagnostics expand R&D structure of collaboration |
Thursday, 02.12.2004 |
|
| Press Release, Berlin |
|
| Epigenomics AG reports third quarter 2004 results |
Wednesday, 03.11.2004 |
|
| Press Release, Berlin |
|
| Epigenomics forms pharmacodiagnostic research collaboration with Biogen Idec in oncology |
Thursday, 07.10.2004 |
|
Press Release, Berlin |
|
| Initial Public Offering of Epigenomics AG: End of Stabilization Period |
Tuesday, 24.08.2004 |
|
| Press Release, Berlin |
|
| Epigenomics AG Meets Key Milestone in Breast Cancer Test Development |
Thursday, 12.08.2004 |
|
| Press Release, Berlin |
|
| Listing of Epigenomics to occur monday july 19, 2004 |
Friday, 16.07.2004 |
|
| Press Release, Berlin |
|
| Epigenomics AG launches IPO on Franfurt Stock Exchange |
Monday, 05.07.2004 |
|
| Press Release, Berlin |
|
| Epigenomics presents positive results from studies using DNA methylation markers for predicting disease recurrence in breast cancer patients |
Monday, 07.06.2004 |
|
Press Release, Berlin |
|
| Epigenomics and academic partners receive BMBF grant to develop novel techniques for early cancer detection based on DNA-methylation |
Tuesday, 27.04.2004 |
|
| Press release, Berlin |
|
| Epigenomics develops technique for sensitive early detection of cancer |
Tuesday, 20.01.2004 |
|
| Press release |
|
| Epigenomics to enter collaboration with AstraZeneca |
Tuesday, 13.01.2004 |
|
| Press release, Berlin |
|
top of the page
|
